Dionex is a leading developer and manufacturer of laboratory and process analytical systems and related products used to isolate, identify, and quantify the components of complex chemical mixtures. Dionex products are used extensively in environmental analysis, and by the pharmaceutical, life sciences, biotechnology, chemical, petrochemical, power generation, food and beverage, and electronics industries. These products are used to meet analytical needs ranging from basic research to in-process quality control. Dionex customers include many of the largest industrial companies worldwide, as well as government agencies, research institutions, and universities.
The Dionex product line offers a broad range of analytical technologies to meet the needs of a growing number of customers. In the area of liquid chromatography, these technologies include ion chromatography (IC), classical high-performance liquid chromatography (HPLC), HPLC using polymeric flowpaths and capillary and nano HPLC. In the area of sample preparation, these technologies include Accelerated Solvent Extraction (ASE®). Dionex chromatography workstations provide reliable start-to-finish automation and multiple instrument control. An extensive and evolving line of columns, accessories, and other consumable products offers customers a range of choices to fill their needs.
Dionex is best known for pioneering IC, a powerful technique that separates ions, or charged molecules. Introduced in 1975, IC is now critically important in determining drinking water quality, environmental contaminants in wastewater, and on-line monitoring of raw materials and production processes in a variety of manufacturing facilities. Today, Dionex is the market leader in the $325 million ion analysis market.
Dionex provides a broad range of products to the $2 billion plus HPLC market. These HPLC products include classical stainless steel systems, HPLC systems for biomolecules using polymeric flowpaths, and capillary and nano HPLC systems for proteomics research. Innovative HPLC capabilities developed by Dionex for analyzing carbohydrates have proven valuable in the development of therapeutic agents for heart disease, AIDS, arthritis, and other medical conditions.
Dionex also develops and commercializes other technologies with demonstrated performance capabilities, such as ASE. ASE is extremely effective for extracting organic compounds from soils, polymers, processed foods, and other materials, and is faster, easier, and more economical than conventional methods.
Based in Sunnyvale, California, Dionex employs more than 1,100 people worldwide and reported revenues of over $327 million for its 2007 fiscal year. Dionex shares trade on NASDAQ under the symbol DNEX.
